Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
Ultrasound is routinely used to screen for HCC. However, its utility is limited by numerous factors, including patient body habitus, operator experience and certain liver conditions, all of which contribute to decreases in sensitivity.
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
Medical imaging components manufacturer Dunlee introduced at this year's RSNA Glassware Solutions, a new program for predicting and managing glassware replacement.
Orthocrat Ltd. has inked agreements with nine major PACS vendors for integration of its TraumaCad digital orthopedic planning system into their electronic capture and archiving system.
Kaiser Permanente will provide an $8 million endowment to the Institute for Healthcare Improvement (IHI) that funds new scholarship programs to allow healthcare professionals to participate in IHI healthcare improvement programs including conferences, tra
The University of Pittsburgh's School of Health and Rehabilitation Sciences (SHRS) has been awarded a five-year, $4.25 million grant from the federal government's National Institute of Disability and Rehabilitation Research (NIDRR) to establish the Rehabi
Eastern Isotopes, a subsidiary of IBA (Ion Beam Applications), has entered into a distribution agreement with Integrated Medical Solutions LLC to offer "Jump Start: A Dementia Program for PET."
SourceOne Healthcare Technologies and PenRad Technologies Inc. have inked a nationwide distribution agreement that gives SourceOne rights to distribute PenRad's mammography information systems.
Siemens Medical Solutions has inked a five-year agreement with Fairview-University Medical Center in Minneapolis, Minn., the largest of seven hospitals owned by Fairview Health Services, to be its sole provider of imaging technology.
Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.
